IP Library Granted Patent US 7,666,830
Granted Patent B2
US 7,666,830 · App. 10/483,892 · Granted Feb 23, 2010

Nutritional composition preventing bacterial overgrowth

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,666,830
App. No.
10/483,892
Granted
Feb 23, 2010
Kind
B2
Abstract

Protein hydrolyzates are used for prevention of bacterial overgrowth. In addition it was shown in sucklings mammals that specific protein hydrolyzates promote an intestinal flore pattern which is similar to the one of mammals raised by their mother. Other advantages are that the hydrolyzate is easier to obtain and simpler to administrate than treatment of bacterial overgrowth with the aid of active principles.

Claims (4)

1. A method for treating and reducing bacterial overgrowth or translocation, the method comprising the step of administering to an individual having bacterial overgrowth or translocation a nutritional composition comprising as a sole source of protein a whey protein hydrolysate, wherein the degree of hydrolysis of the whey protein hydrolyzate is greater than 30%.

2. A method for the prevention of necrotizing enterocolitis, septicemia and/or reduced availability of nutrients, comprising the step of administering to an individual at risk of same a nutritional composition comprising as a sole source of protein a whey protein hydrolyzate, wherein the degree of hydrolysis of the whey protein hydrolyzate is greater than 30%.

3. A method for treating and reducing bacterial overgrowth or translocation, the method comprising the step of administering to an individual in need of same a therapeutically-effective amount of a nutritional composition comprising as a sole source of a protein a whey protein hydrolysate, wherein the degree of hydrolysis of the protein hydrolyzate is greater than 30%.

4. A method for the treatment of necrotizing enterocolitis, septicemia and/or reduced availability of nutrients, comprising the step of administering to an individual suffering from same a therapeutically-effective amount of a nutritional composition comprising as a sole source of protein a whey protein hydrolyzate, wherein the degree of hydrolysis of the whey protein hydrolyzate is greater than 30%.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2004
From: GARCIA-RODENAS, CLARA L.; BALLEVRE, OLIVIER; ROCHAT, FLORENCE
To: NESTEC S.A.
Reel/Frame 014917/0395 →